====== Laura Desveaux ======

{{ ::headshot-180x180.jpeg?200|}}

**Laura Desveaux**, PhD is a Canadian behavioural scientist based in [[canada:Ontario]].

===== Career and Affiliations =====

==== Women's College Research Institute ====

Desveaux is an Adjunct Scientist at the [[Women’s College Research Institute]], and an Innovation Fellow for the [[Women’s College Hospital]] [[Institute for Health System Solutions and Virtual Care]].((//Laura Desveaux.// (2020). Women’s College Research Institute. https://archive.ph/s9kup))

==== University of Toronto ====

Desveaux is an Assistant Professor in the [[Institute of Health Policy, Management and Evaluation]] at the [[University of Toronto]].((University of Toronto. //Laura Desveaux.// Institute of Health Policy, Management and Evaluation. Retrieved May 7, 2022, from https://archive.ph/DhdwZ))

==== Ontario COVID-19 Science Advisory Table ====

Desveaux formerly served as a member of the [[Ontario COVID-19 Science Advisory Table]] and co-chair of its Behavioural Science Working Group.((//About Us.// (2021, June 30). Wayback Machine; Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20210630064946/https://covid19-sciencetable.ca/about/#desveaux-laura))

==== Trillium Health Partners ====

Desveaux is the Scientific Lead & Learning Health System Program Lead at [[Trillium Health Partners]].((//Laura Desveaux, PhD.// LinkedIn. Retrieved May 7, 2022, from https://www.linkedin.com/in/lauradesveaux/)) She is also the Executive Director of [[Women Who Lead]].

==== E2I Consulting ====

Desveaux is a principal of [[E2I Consulting]] alongside [[Noah Ivers]].((//Experienced, Evidence-Based Consulting.// E2I Consulting. Retrieved May 7, 2022, from https://archive.ph/FNKqm))

==== Women in Medicine Summit ====

Desveaux is associated with the [[Women in Medicine Summit]].((//Laura Desveaux.// Women in Medicine. Retrieved May 7, 2022, from https://archive.ph/HG3HV)) Sponsors for the summit have included [[3M]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[pharmaceutical_companies:Bristol-Myers Squibb]], [[pharmaceutical_companies:Celgene]], [[pharmaceutical_companies:Genentech]], [[medical_technology_companies:Labcorp]], [[pharmaceutical_companies:Merck]], [[Morgan Stanley]], [[medical_technology_companies:Natera]], [[pharmaceutical_companies:Pfizer]], [[Seattle Genetics]], [[medical_technology_companies:Tempus]], [[US Army Health Care Recruiting]], [[US National Library of Medicine]], [[Vanium Group]], and [[Yale Cancer Center]].((//Sponsors.// Women in Medicine. Retrieved May 7, 2022, from https://www.womeninmedicinesummit.org/sponsors))
===== Research =====

Desveaux's research interests include implementation science, [[behaviour change]], program evaluation, and complex interventions.

==== COVID-19 ====

In February 2021, Desveaux authored a pre-print paper on [[vaccine hesitancy]] in non-physician health care workers in regards to [[COVID-19 vaccines]].((Desveaux, L., Savage, R. D., Tadrous, M., Kithulegoda, N., Thai, K., Stall, N. M., & Ivers, N. M. (2021). //Beliefs associated with Intentions of Non-Physician Healthcare Workers to Receive the COVID-19 Vaccine in Ontario, Canada.// medRxiv. Preprint. https://doi.org/10.1101/2021.02.19.21251936))